U.S. biotech firm Novavax said on Thursday its two-shot COVID-19 vaccine showed an overall efficacy of 89.3% in a major Phase 3 clinical trial in Brit
https://ift.tt/eA8V8J< January 29, 2021 at 09:10PM> from The Hindu - International https://ift.tt/3iXcrus
Coronavirus | Novavax vaccine highly effective, but not against South Africa variant
No comments: